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Agnes Doszpoly 
THE ROLES OF DANIO RERIO NRF2 PARALOGS IN RESPONSE TO OXIDATIVE 
STRESS IN THE PANCREATIC β-CELL 
 Oxidative stress can disrupt cellular homeostasis, leading to cellular dysfunction 
and apoptosis. The Nrf2 transcription factor regulates the antioxidant response in cells by 
binding to antioxidant response elements (ARE) in DNA and activating genes of enzymes 
that combat oxidative stress. During the pathogenesis of diabetes mellitus (DM), β-cells 
are exposed to increased amounts of reactive oxygen species (ROS) that cause oxidative 
stress. Zebrafish (ZF) are excellent models for studying the dynamic mechanisms 
associated with DM pathogenesis, and we recently developed a ZF model of β-cell 
apoptosis caused by ROS.  Two paralogs of Nrf2 have been identified in ZF, Nrf2a and 
Nrf2b, but their roles in pancreas development and/or β-cell survival are unknown. To 
investigate their roles, Nrf2a and Nrf2b antisense morpholinos (MO) were injected into 
Day 0 ZF embryos and analyzed over time. While Nrf2a MO showed no obvious 
phenotypes compared to WT, Nrf2b MO exhibited reduced pancreas size and islets with 
disrupted morphology. Ins:NTR Nrf2a MO showed reduced β-cell loss upon exposure to 
Metronidazole (MTZ) under generation of ROS compared to WT.  Sequence analysis of 
ZF nrf2b in 3-day post-fertilization (dpf) embryos revealed a novel splice variant 
containing an additional exon that has not been described.  Further investigation of Nrf2a 
and Nrf2b is likely to yield additional insights regarding the function and regulation of 
the NRF2-signaling pathway and their roles in β-cell protection under oxidative stress. 
      
Amelia K Linnemann, PhD, Chair 
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INTRODUCTION 
Diabetes Mellitus  
 Diabetes mellitus (DM) is a chronic disorder of glucose homeostasis that results 
in high concentrations of blood glucose throughout the body [1]. Current statistics show 
that DM remains the 7th leading cause of death in the United States, with a prevalence of 
30.3 million in 2015.  There are roughly 1.5 million new diagnoses each year and by 
2040, approximately 642 million cases are predicted worldwide [2].  There are two major 
types of diabetes: Type 1 (T1DM) and Type 2 (T2DM).  T1DM, also known as ““insulin-
dependent diabetes”, is an autoimmune disease triggered by an immune attack on the β-
cells in the pancreatic islets of the endocrine pancreas, causing β-cell destruction and 
dysfunction, eventually leading to chronic glucose homeostatic disorder [3].  T2DM is 
defined as the body’s inability to utilize the insulin it produces for metabolizing blood 
glucose.  In T2DM, a key difference from T1DM is that, while there may still β-cell 
dysfunction, the most likely cause of diagnosis is insulin resistance caused by obesity [4].  
Diabetes can lead to a number of additional complications and side effects, including 
blindness, higher risk of strokes and heart attacks, and neuropathy, due to complications 
from untreated high blood glucose concentrations [5]. 
 DM physiology involves the destruction and dysfunction of β-cells in the 
pancreatic islets of the endocrine pancreas.  β-cells are responsible for the synthesis, 
storage, and release of insulin for regulating glucose metabolism [6] (Fig. 1).  Insulin is a 
peptide hormone that maintains normal blood glucose levels by facilitating cellular 
glucose uptake for proper homeostatic conditions [7][8].  β-cells are integral to the proper 
control of pancreatic physiology and are vital against the development of diabetes.  In 
	 2 
T1DM or T2DM, β-cell mass and function are diminished, leading to insufficient insulin 
secretion and hyperglycemia [9].  Thus, survival of these cells is a key aspect of diabetes 
prevention.  There are several biological mechanisms by which β-cells could be 
destroyed [10]. One of these is through endoplasmic reticulum (ER) stress that occurs 
with the generation of reactive oxygen species (ROS). 
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Oxidative Stress  
 Oxidative stress is defined as a disturbance or imbalance between the production 
of oxidants, or ROS, from sources such as the mitochondria and ER, and antioxidant 
defenses in the cellular environment [11].  Such an imbalance in the system can lead to a 
range of impacts related to cellular homeostasis, including tissue damage, inflammation, 
 
 
Figure 1. Diabetes physiology of the pancreas and β-cells.  The pancreas consists 
of the endocrine and exocrine systems.  The pancreatic islets, part of the 
endocrine system, are small groups of individual cells, including α, δ, and β-cells.  
α-cells release glucagon, while β-cells synthesize and secrete insulin.  In a 
diabetic state, the β-cells are destroyed by the immune system and fail to secrete 
insulin into the blood. 	
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and damaged nucleotides that can further cause impaired protein production (Fig. 2).  In 
DM, oxidative stress can have roles in the production of tissue damage in the β-cells that 
can lead to a number of negative impacts on cellular survival, including insulin synthesis 
and release upon high blood glucose presence [12]. 	
Oxidative Stress in β-cells 
 Oxidative stress, in the context of β-cells, is an ideal model for T1DM for 
understanding the mechanisms of cell survival and death.  β-cells are highly susceptible 
to oxidative stress [13]. During the pathogenesis of DM, β-cells are exposed to increased 
amounts of ROS that cause oxidative stress [14].  ROS are generated during the 
metabolism of glucose and serve as important signaling messengers to trigger insulin 
secretion and β-cell expansion in response to elevated levels of glucose.  Chronic 
exposure to ROS under hyperglycemic conditions can lead to cellular damage, impaired 
glucose-stimulated insulin secretion, and eventually cell death [15]. 
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NRF2 and the Antioxidant Response  
 Balance is key for proper cellular functions and survival.  Enzymes in cells are 
equipped to combat such shifts in the balance.  These systems and molecules, 
 
 
Figure 2.  Oxidative stress and its effects.  An imbalance between the 
antioxidants and free radicals in the cellular environment causes a 
disturbance in the system that can lead to inflammation, tissue and nuclear 
damage, and even cell death. 
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collectively, are known as the antioxidant response (ARE) factors. Nuclear factor 
erythroid 2-related factor 2 (NRF2) is a transcription factor and master regulator of the 
antioxidant response of cells [16]. NRF2 regulates the expression of AREs and target 
proteins and protect against oxidative damage, influencing a number of biological 
processes such as aerobic respiration, embryonic development, inflammation, and 
carcinogenesis [17-19].  
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 NRF2 protein expressions in low, and Nrf2 is bound to its partner, Kelch like-
ECH-associated protein 1 (KEAP1) and Cullin 3 (Cul3) in the cytoplasm [20].  However, 
 
 
Figure 3. NRF2 activation mechanism.  Under homeostatic conditions, the 
transcription factor NRF2 is present at low levels in the cytoplasm, bound to 
KEAP1 and Cul3, which are E3 ubiquitin ligases.  Under non-oxidative stress 
conditions, NRF2 is ubiquitylated by KEAP1.  Cul3 and is sent to proteasomal 
degradation.  During oxidative stress conditions, NRF2 becomes phosphorylated 
and is released from KEAP1, allowing for NRF2 transport to the nucleus, where 
it binds to antioxidant response elements (AREs) in the promoters of genes 
involved in antioxidation. 
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under oxidative stress, NRF2 is released from KEAP1 and translocates to the nucleus of 
the cell, where it binds to a DNA promoter and AREs located in proximity to promoters 
of target genes, activating gene transcription and their proteins. KEAP1 contains redox-
sensitive cysteines that release NRF2 in the presence of oxidative stress and ROS [21] 
(Fig.3).  Oxidative stress disrupts these cysteine residues and, therefore, disrupts the 
KEAP1-Cul3 ubiquitylation of NRF2.  While NRF2 is in the nucleus, it combines with 
and forms heterodimers with small Maf proteins and the heterodimer complex binds to 
AREs to enhance initiation of transcription [22]. 
 The NRF2 protein consists of six NRF2f-ECH homology (Neh) domains, 
originally assigned based upon regions identified as homologous between cross-species 
orthologs of NRF2 [23]. Each domain serves in key NRF2 functions.  The Neh1 domain 
contains the DNA binding functions and serves to heterodimerize with small MAF 
proteins such as MAFF, MAFG, and MAFK [24].  Transactivation activities are 
promoted by the Neh3, Neh4, and Neh5.  The Neh2 domain facilitates NRF2 binding to	
KEAP1 [21][25].  The Neh3 domain is also suggested to be involved in NRF2 protein 
stability [26].  The Neh4 and Neh5 domains also bind to cAMP Response Element 
Binding (CREB) proteins that are involved in intrinsic histone acetyltransferase activity 
[21].  Lastly, Neh6 domain is responsible in sensing redox and contains degrons involved 
in a redox-insensitive process of degradation of NRF2 [24][27].  Collectively, these 
domains ensure appropriate regulation of NRF2 transcriptional activities in response to 
ROS. 
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NRF2 in Diabetes Research 
 Recent studies have described mechanisms for NRF2 antioxidant regulation in 
pancreatic β-cells and the involvement of these processes in the pathogenesis of T1DM.  
Marasco et al., 2018 reported a novel finding that IL-6-driven ROS reduction is 
associated with an increase in NRF2 translocation to the mitochondria to decrease 
mitochondrial activity and stimulate mitophagy [28].  NRF2 regulation is likely to be 
important in the context of understanding β-cell protective mechanisms under oxidative 
stress conditions. IL-6-driven ROS reduction is associated with an increase in NRF2 
translocation to the mitochondria to decrease mitochondrial activity and stimulate 
mitophagy.  Additionally, studies have suggested that the NRF2 pathway is implicated 
in diabetic damage to the pancreas, heart, and skin, among other cell types and tissues in 
T2DM [29].   
 
Zebrafish: an Important Developmental Model 
 Zebrafish models have been used for developmental studies due to their rapid 
embryonic stage development compared to other animal models [30].  Zebrafish are also 
an important vertebrate model for studying developmental toxicity with implications for 
understanding human embryonic development [31].  An advantage in the zebrafish 
genome is that there are often two copies of genes that are only present as a single copy 
in mammals.  This allows for additional insights into the functions of the human 
counterpart [22].   
 The multiple gene copies present in the zebrafish genome are suggestive of the 
process of subfunction partitioning. A whole-genome duplication occurred during the 
divergence of fish and mammals [31] which gave rise to paralogous genes in the 
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zebrafish genome that are the duplicates of the single genes in mammals.  Additionally, 
through this process, zebrafish paralogs have partitioned multiple functions of their 
mammalian orthologs [32][33].  
 
nrf2a and nrf2b: Duplicate nrf2 genes in the Zebrafish Genome 
 Zebrafish possess six nrf –related genes, including two nrf2 genes. The original 
zebrafish nrf2 gene, designated as nrf2a, is positioned on chromosome 9 containing the 
single hoxda cluster [34]. Timme-Laragy et al., 2011 cloned a novel zebrafish nrf2 
paralog, nrf2b [34].  The human NRF2 gene is located in a similar fashion adjacent to the 
HOXD cluster. In contrast, nrf2b is located on chromosome 6, near miR-10d2 and other 
Hox-associated genes (atp5g, lnp, and mtx2).  This region corresponds to that of 
the hoxdb gene cluster.  Overall, the genomic mapping data demonstrates extensive 
conservation of nrf and hox genes in both zebrafish and human genomes.  This 
conservation provides strong evidence that the zebrafish nrf genes are orthologs of the 
corresponding human NRF genes.   We therefore propose that studying nrf2a and nrf2b 
genes in zebrafish will provide important insights into the regulation and functions of 
human NRF2 [34].   
 Initial sequence comparisons between nrf2a and nrf2b showed that nrf2b is 
lacking an exon corresponding to exon 3 in nrf2a (Fig. 4).  Further, amino acid sequence 
alignments show that Nrf2b and Nrf2a are 25.1% identical overall, of which most of the 
identity match occurs in the conserved Neh domains. Comparisons of the Neh1 domain 
show thatNrf2a and Nrf2b share 73 and 41% identity, respectively.  Neh1 is an important 
region, as it contains the CNC homology region and the basic-leucine zipper domains that 
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allow NRF2 to heterodimerize with small MAF proteins and bind to DNA.  Further 
comparisons revealed that Nrf2b lacks the Neh4 transactivation. [35][36]. 
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Figure 4.  Coding sequence alignment of nrf2a and nrf2b with exons and homology 
using Clustal Omega.  Exons 1 highlighted in yellow; 2 in green; 3 in blue; 4 in pink; 
and 5 in purple.  Overall sequence identity is 51.86% between the two entries.  nrf2b 
is lacking a region corresponding to exon 3 in nrf2a.  
 
 
 Timme-Laragy et al., 2011 also compared Neh domains of both ZF Nrf2a and 
Nrf2b to human NRF2 by analyzing the number of conserved amino acids over the total 
number in the specific domain.  Their findings show that, overall, ZF Nrf2a has more 
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conserved amino acids in all Neh domains than Nrf2b, suggesting closer identity to 
human NRF2.   
 
Antisense Morpholinos for Studying Gene Expression 
 Reverse genetics, including gene expression knockdown technologies, were used 
to study the functions of Nrf2a and Nrf2b in pancreatic β-cells under oxidative stress 
conditions.  Antisense morpholinos (MO) are tools in molecular biology used for 
studying gene expression [37][38].  They are oligonucleotides with a 
methylenemorpholine ring backbone that bind to specific target sites within an mRNA 
sequence (Fig. 5).  Morpholinos essentially inhibit mRNA translation by blocking other 
small molecules from accessing specific sequences on the mRNA [38].  The specificity of 
morpholinos is arguably favorable under proper experimental conditions.  This is due in 
large to the 15 contiguous bases that the morpholino must bind to in order to ensure 
blocking a gene transcript, which constitutes sufficient sequence information for a 
selected gene of interest [39].  However, the possibility of undesirable off-target effects 
must be considered when administering morpholino dosages in experiments, as there has 
been evidence to suggest secondary sequence-specific p53 activation [40]. To avoid these 
effects, p53 inhibition could be considered applicable to these systems to suppress off-
target effects caused by knockdown technologies such as morpholinos. 
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Figure 5.  Schematic of the mechanisms by which morpholinos inhibit targeted 
gene expression. After gene transcription, the mRNA is exported out of the 
nucleus to bind to the ribosomal complex and begin protein translation.  
However, when a morpholino technique is used, the morpholino binds to the 
mRNA after the initiation complex and blocks mRNA translation, resulting in a 
reduced amount of expressed protein present.  
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Oxidative Stress in the Zebrafish Model 
Having a vertebrate model to study ROS dynamics in situ and the factors involved 
in their mechanisms would provide insights into the discoveries and testing of 
therapeutics for a variety of metabolic diseases such as DM [41].  Kulkarni et al., 2018 
proposed a model to study ROS generation in zebrafish in a β-cell-specific manner using 
a hybrid chemical genetic approach with the prodrug Metronidazole (MTZ) and a 
nitroreductase (NTR) system [42]. The model uses a transgenic NTR-expressing 
zebrafish line, Tg(ins:Flag-NTR)s950, that expresses insulin promoter-driven NTR in β-
cells exposed to specific concentrations of MTZ in a dose and time-dependent manner to 
study the generation of ROS throughout development.  It ultimately showed strong 
evidence that the system effectively ablated β-cells under the insulin promoter to generate 
ROS and model T1DM pathogenesis [42].  
The NTR-MTZ system has been implemented to efficiently ablate cells in a 
tissue-specific and temporally controllable manner [43]. The mechanism behind the 
technique is based on the Escherichia coli enzyme NTR to convert MTZ into a cytotoxic 
metabolite [44].  NTR is reduced by NADH or NADPH and causes MTZ to bind, become 
electrochemically reduced and then be converted into a DNA cross-linking agent 
responsible for ablating NTR-expressing cells [45-47].   When a fluorescent protein 
expressed under a tissue-specific promoter is treated with MTZ, it can induce rapid 
destruction of targeted cell population [42].  Through these interactions, MTZ is able to 
remain confined to the NTR-expressing cell; thus, cells near the targeted area are not 
affected, making the system specifically targeted.  NTR-expressing cells can be 
monitored throughout the duration of the ablation through fluorescent microscopy.   
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Kulkarni et al.,2018 exposed INS-NTR ZF embryos to 7.5 mM MTZ for up to 24 
hours, resulting in ablation of β-cells coincident with CellROX green staining indicated 
high levels of ROS [48][49].  ROS staining was observed in the β-cell nuclei within 1 hr 
of MTZ treatment, and gradually increased by almost 4-fold during the 24 hr treatment 
regimen.  Further experiments with a range of MTZ concentrations concluded that a 
concentration as low as 2.5 mM was sufficient enough to induce β-cell death over the 
treatment duration [48].  The MTZ-NTR system is relevant to T1DM because ROS 
generation is specifically targeted to β-cell ablation and functional impair, much like the 
underlining physiology of T1DM pathogenesis.  An advantage to this system is the ability 
to manipulate ROS generation under varied contexts due to the dependence of the dose of 
MTZ treatment, which can be easily administered for ZF experimentation methods. 
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HYPOTHESIS 
 
 Based on the roles of NRF2 in the regulation of oxidative stress, we hypothesized 
that Nrf2a and Nrf2b in zebrafish would regulate oxidative stress to protect the β-cells 
from ROS and have similar effects on mitigating ROS.   Prior literature has shown that 
Nrf2a is more closely related to human NRF2, we further proposed that Nrf2a could be 
the more active, or preferred paralog of the two ZF Nrf2s, and be critical for β-cell 
resistance to ROS.  To test the working hypothesis, the following experimental proposal 
was formed: 
 
Investigative Questions 
1. Are Nrf2 paralogs essential for exocrine or endocrine pancreas development? 
2. Do Nrf2a and/or Nrf2b protect against oxidative stress in ZF β-cells? 
 
Experiment 1.  Knockdown expression of nrf2a and/or nrf2b by using antisense 
morpholinos.  Using antisense morpholino technology to study protein function under 
knockdown conditions, we designed experiments that tested the functions of Nrf2a and 
Nrf2b under oxidative stress specific to the β-cell using the MTZ-NTR mechanism as 
done previously by Kulkarni et al., 2018.   
 
Experiment 2. Determine phenotype of pancreas (overall pancreas and islet sizes) 
morphology and composition relative to overall embryonic development phenotypes 
using epifluorescence and confocal microscopy. 
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The investigation would be narrowed down to focus on the effects on pancreas 
development of the Nrf2a and Nrf2b MOs, as well as investigate Nrf2a MO and Nrf2b 
MO in the islets during oxidative stress induced by MTZ to model T1DM β-cell 
dysfunction.   
 
Experiment 3.  Inject morpholinos targeting Nrf2a and/or Nrf2b into insulin RFP, insulin 
NTR transgenic lines and determine response to MTZ in the presence and absence of 
Nrf2a and/or Nrf2b.  Gene expression analysis will give insights to the underlying genetic 
regulations that occur in response to the Nrf2 paralog knockdown and will be analyzed 
through qPCR and gene specific primers in both MTZ treated and control embryos.   
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MATERIALS AND METHODS 
Zebrafish Maintenance and Embryo Collection 
Zebrafish were maintained at 28.5°C in a recirculating aquaculture system enclosed in a 
cabinet and subjected to 14-/10-hr light/dark cycle in accordance with institutional 
policies under IACUC oversight.  Embryos were collected at spawning and maintained in 
a 28.5°C incubator in egg water-filled petri dishes.  Transgenic zebrafish embryos were 
genotyped by epifluorescence at 48 hpf using a Leica M205FA dissecting microscope. 
 
Morpholino Injections 
Antisense morpholinos were purchased and stored in 4°C.  Upon use, morpholinos were 
prepared with the injection mix at a 1:10 dilution along with Alexa Phenol Red dye.  
Injection mix was administered using a microinjector into 1-cell stage ZF embryos.  
Table 1 provides the sequences for both Nrf2a and Nrf2b MO. 
 
Table 1.  Sequences for Nrf2a and Nrf2b MO 
Name Sequence (5’ à 3’) 
Nrf2a MO CATTTCAATCTCCATCATGTCTCAG 
Nrf2b MO AGCTGAAAGGTCGTCCATGTCTTCC  
 
 
Chemical Treatments 
1-Phenyl-2-thiourea (PTU; Acros #207250250) supplementation at 0.003% was used to 
prevent pigmentation in all embryos after gastrulation stages.  Metronidazole (MTZ) 
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(Sigma #095K093) solutions of 7.5mM were prepared in egg water (0.1% instant ocean 
salt, 0.0075% calcium sulfate) that was supplemented with PTU. Larvae were then 
paralyzed with 0.01% tricaine (Sigma #A-5040). 2 and 3dpf ZF embryos were fixed with 
2.5% fixing solution (include ingredients and prep for this). 
 
Antibody Staining, Immunofluorescence, and Confocal Microscopy Image Collection 
Primary antibodies were stained at 1:100 ratio (insulin) and 1:200 (glucagon) for 
samples, with secondary antibodies at 1:500 each. After staining, embryos were mounted 
on slides in Vectashield (Vector Labs H-1000), mounted on glass-bottom petri dishes 
(Mattek #P35G-0-10-C) in 0.5% low melt agarose (Sigma #A9414). Imaging was 
performed on Zeiss LSM 700 confocal microscope at 40X zoom. 
 
mRNA Measurements 
RNA from ZF embryos was collected at 3 dpf and extracted using Trizol 
Phenol/Choloform extraction and Qiagen RNeasy kit with Ethanonl precipitation and 
DNAse treatments. CDNA was synthesized at 250ng RNA input using NAME OF KIT. 
qPCR analysis was measured with Quant Studio3 equipment on with iTAQ Master Mix 
(Applied Biosystems). 
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nrf2b Isoform Cloning and Sequencing 
PJET 2.1 Cloning kit (Thermo Fisher Scientific #K1231) was used to clone the nrf2b 
PCR products into the vectors. Positive-stained bacterial E.Coli colonies were picked and 
plasmid DNA isolation was performed.  Sequencing was performed by ACGT. 
 
Primer Design for PCR 
Primers for nrf2a, nrf2b, and beta actin for ZF were designed using NCBI Primer 
BLAST (NCBI References: Nfe2l2a (mRNA): NM_182889.1 Nfe2l2b (mRNA): 
NM_001257183.1) with exon-exon junctions and were validated on sample ZF DNA 
before experimentation.  Table 2 provides the primer sequences for both nrf2a and nrf2b.   
 
Table 2.  Primer sequences for nrf2a and nrf2b 
Name Sequence (5’ à 3’) 
nrf2a forward TCACTCCCAGAGTTGCAGCAG 
nrf2a reverse CACTTCTGTTTGAGCCGAGC 
nrf2b forward ATCCCTTGTTGTCTGCCCTG 
nrf2b reverse TGGATCGGGGAGGTTAGGTT 
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PCR, qPCR and Gel Electrophoresis 
Q5 Hot Start High-Fidelity Polymerase (NEB M0493) was used for PCR reactions on 3 
dpf ZF cDNA. Itaq Syber Green Mastermix kit was used for the qPCR reactions, 
performed in biological triplicates and technical duplicates.  2% and 1% agarose gels 
(Agarose in TEB) were made and loaded with samples run at 100V for 70 mins, stained 
with GelRed imaged under blue light.  
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RESULTS 
Pancreatic phenotypes exhibit disrupted morphology and reduced pancreas size in Nrf2b 
MO ZF embryos  
 Our approach to study Nrf2 paralog functions under oxidative stress in the 
pancreatic β-cells began by looking at effects of Nrf2a and Nrf2b MO on the overall 
pancreas during embryonic development as compared to controls.  The intent was to 
investigate and define pancreatic phenotypes generated by the effects of the morpholinos.  
Transgenic Ptf1a:GFP and Ins:red ZF were crossed, as these fish have fluorescently 
labeled exocrine and endocrine pancreas. Nrf2a and Nrf2b MO were separately 
administered at doses 2, 4, and 6ng at 1 cell stage.  Embryos were allowed to develop 
until 3 dpf when they were imaged for pancreatic phenotypes.  Fig. 6 (A) shows the 
images for Nrf2b MO and (B) the summary table of pancreatic phenotypes for Nrf2a MO 
and Nrf2b MO dosages.  Overall, Nrf2a MO did not present any obvious pancreatic 
phenotypes in the range of MO dosages administered.  However, Nrf2b MO exhibited 
disrupted morphology and reduced pancreas size at both the 2 and 4ng dosages. In 
addition to reduced pancreas size, there were also disrupted islets in some of the embryos 
as well.  From these observations, a Nrf2b MO phenotype was identified and 
distinguished between the two Nrf2 paralogs. 
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Figure 6.  Pancreatic phenotype images of Nrf2a and Nrf2b MO.  3dpf 
Ptf1a:GFP and Ins red zebrafish embryos were injected with 0, 2, 4, and 6ng 
Nrf2b MO, respectively, and allowed to develop until 3dpf, when pancreatic 
phenotypes were analyzed.  (A) Representative images of 3dpf embryos with no 
morpholino injection control samples (left) 2ng Nrf2b MO (center) and 4ng 
Nrf2b MO (left). (B) Summary table of Nrf2b MO pancreatic phenotypes and 
observations.	
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Nrf2a MO reduces β-cell loss after MTZ treatment 
 To further investigate Nrf2 paralog functions, I next analyzed β-cell survival 
under oxidative stress in MO vs. controls.  My experimental design involved the use of 
the Ins:NTR-MTZ system for the generation of β-cell-specific ROS and a fluorescently 
labeled tag under the insulin promoter to allow visual examination of insulin positive 
cells. Fig. 7 describes the experimental timeline. Transgenic ZF (INS:NTR S950 X 
Ins:kaede) were crossed and embryos injected with 4ng Nrf2a MO at 1 cell stage.  At 
2dpf, embryos were fluorescently sorted for NTR and kaede positive transgenes.  7.5mM 
MTZ was administered to embryos for 24hrs after which embryos were immediately 
fixed with formaldehyde.  Antibody staining and washes followed with confocal 
microscope imaging of islets.  Fig. 8 shows representative confocal images and 
quantitative analysis of insulin positive cells for the experiment.   For groups with no 
MTZ treatment, the presence of insulin positive β-cells seemed not to be affected in both 
control and Nrf2a MO groups.  MTZ-treated control groups showed almost no presence 
of β-cells in the islet after treatment; however, Nrf2a MO MTZ treated group showed an 
increase of β-cell survival compared to controls.  Quantitative analysis of the presence of 
insulin positive cells for each control group showed significance in Nrf2a MO groups for 
+/- MTZ treatment.  Thus, contrary to our initial hypothesis, Nrf2a MO reduced β-cell 
loss after MTZ treatment. 
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Figure 7. Zebrafish Nrf2a Morpholino MTZ experimental timeline. INS:NTR and 
WT transgenic ZF embryos (ins:kaede X S950 fish lines) were injected with 4ng 
Nrf2a MO at 1 cell stage.  INS:NTR positive embryos were sorted at 2 dpf and 
administered 7.5 mM MTZ for 24hrs. Embryos were fixed with 3% formaldehyde 
and stained with primary and secondary antibodies for insulin and glucagon.  
Embryos were imaged with confocal microscope. 
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A        B. 
 
Figure 8. Nrf2a MO reduces β-cell loss after MTZ treatment. (A) Representative 
images of 3dpf embryos in the presence or absence of MTZ treatment for both 
controls and 4ng Nrf2a MO groups. No MTZ treatment resulted in β-cell survival 
in both controls and MO (top row); interestingly, while control group β-cells did 
not survive MTZ treatment (bottom left), the Nrf2a MO group showed β-cell 
survival and reduced loss after treatment (bottom right), suggesting a protective 
mechanism against ROS upon Nrf2a MO knockdown. (B) β-cell quantification for 
control and Nrf2a MO ZF in the presence of MTZ treatment or control MO.  
Number of β-cells after MTZ treatment between controls and Nrf2a MO are 
significant, averaging to around 3 to 12 cells, respectively. 
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Gene expression analysis of MTZ-treated Nrf2a MO and Control ZF suggests minute 
upregulation of nrf2b in Nrf2a MO embryos  
 Next, I addressed the mechanisms by which Nrf2a MO expression enhanced β-
cell survival in response to MTZ treatment by targeting gene transcripts for nrf2a and 
nrf2b with qPCR.  INS:NTR fish were crossed and injected with 4 ng of Nrf2a MO at 1 
cell stage.  At 2 dpf, embryos were sorted for INS:NTR positive transgenes with a 
fluorescence microscope.  These embryos were then exposed to 7.5 mM MTZ for 3 or 
24hrs, or vehicle, and RNA was isolated for each group followed by cDNA conversion.  
qPCR was then performed to measure mRNA expressed from the β-actin, nrf2a, and 
nrf2b genes.  qPCR analysis for delta Ct values was calculated between nrf2a and nrf2b 
relative to β-actin.  Values were normalized to controls for comparison purposes.  The 
expression of nrf2a mRNA levels remained higher in the Nrf2a MO fish the longer the 
MTZ treatment, which was anticipated due to the actions of the morpholino.  After 24hrs 
of MTZ, however, nrf2a expression decreases.  In contrast, nrf2b expressions remained 
slightly higher after 3hr MTZ and nearly equal to control at 24hrs MTZ.  A multi-way 
ANOVA performed on the data confirmed no significance (Fig. 9). 
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Figure 9.  qPCR analysis of nrf2a and nrf2b gene expression in both Control and 
Nrf2a MO embryos after 0, 3, and 24 hr MTZ treatment.  A-B: gene expression 
for nrf2a in Nrf2a MO and controls (A) and nrf2b. C-D: Data normalized to 
Control values for each time point.  Multi-way ANOVA concluded no significance 
between the data.  The  nrf2a expression levels remained high in the Nrf2a MO the 
longer the MTZ treatment.  After 24hrs of MTZ, however, nrf2a expression 
decreased. nrf2b expressions remained slightly elevated.  
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Sequence alignment of 3dpf ZF cDNA reveals novel splice variant of nrf2b 
 Initial PCR analysis was performed on 3dpf ZF cDNA to validate the designed 
primers for both nrf2a and nrf2b. Expected product sizes were 156bp and 186bp for nrf2a 
and nrf2b, respectively. Gel electrophoresis results showed both bands of products at the 
expected lengths; however, an additional band appeared in the nrf2b lane that was 
slightly greater in product size than the expected product (~200 bp).  The new band 
appeared for each repetition of this procedure, eliminating the possibility of random 
product formation (Fig. 10).  
	 31 
 
  
 
Figure 10. Sequence alignment of 3dpf ZF cDNA reveals novel splice variant of 
nrf2b. (A) Agarose gel electrophoresis showing PCR products of nrf2a (lane 2) 
and nrf2b (lane 3).  Note the two products formed by nrf2b primers at lengths 186 
bp (expected) and ~210 bp. (B) Proposed model of nrf2b splice variant.  
Sequencing analysis revealed an inserted product between exons 3 and 4 that 
corresponded to the change in product size in gel electrophoresis results.	
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DISCUSSION 
 Oxidative balance is key for cellular survival.  We examined the master 
antioxidant regulator NRF2 paralogs, Nrf2a and Nrf2b, in the ZF model for investigating 
their roles in β-cells under oxidative stress for diabetes pathogenesis.  The first 
experiment sought to develop a phenotype of the overall pancreas in both Nrf2a and 
Nrf2b ZF embryos as compared to controls, which resulted in a disrupted morphology in 
the Nrf2b morphants.  Next, we examined the ZF islets under oxidative stress conditions 
in both control and Nrf2a MO embryos.  β-cell specific oxidative stress was induced 
using the MTZ-NTR system as previously described by Kulkarni et al., 2018.  Antibodies 
for both insulin and glucagon were used to visually represent the islet for confocal 
microscopy analysis.  Results presented that while control MTZ treated embryos showed 
little to no insulin positive cells, Nrf2a morphants showed a significantly greater number 
of cells remaining after treatment, contrary to the initial hypothesis of β-cell death.  After 
discovering that Nrf2a MO reduces the loss of β-cells under oxidative stress conditions, 
we then further analyzed the gene expression levels for nrf2a and nrf2b in these embryos 
and found that nrf2b gene expressions were slightly upregulated in the Nrf2a MO 
embryos after 24hrs MTZ as compared to controls.  
 A significant find from this study is that Nrf2a MO reduces β-cell loss after MTZ 
treatment. There are a couple of hypotheses that could explain this.  The first hypothesis 
is that Nrf2b acts as a compensatory upregulator for Nrf2a under knockdown conditions.  
This would suggest an increase of the Nrf2b transcript in the Nrf2a MO during high 
levels of ROS from the MTZ treatment (1-6 hrs) to accommodate the decrease in protein 
production of Nrf2a from the mechanisms of the morpholino.  The gene expression 
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analysis seems to indicate a slight increase in nrf2b levels in the Nrf2a MO at 3 and 24hr 
MTZ when compared to controls. This evidence could indicate a dynamic relationship 
between the Nrf2 paralogs during stressed cellular environments.  An important note is 
that the morpholino essentially reduces gene expression for the whole-body organism. β-
cell DNA represents a very small portion of the entire ZF genome, and detecting β-cell 
specific protein changes and gene regulation are an additional challenge for studies like 
these without direct protein quantification and DNA isolation.   
 It is also suggestive that the β-cells that survived the MTZ treatment are actually 
regenerated cells after ROS exposure.  This phenomenon could be tested in ZF with the 
use of the ins:kaede-UV method, which uses a green-to-red photoconversion of kaede in 
β-cells after being exposed to UV light to indicate regenerated cells [50].  Applying this 
method to the study would allow further insights into the counterintuitive observation of 
how the β-cells survived the 24hr MTZ treatment in Nrf2a MO.  Additional staining for 
ROS by CellROX would provide specifics on the amount of ROS, as well as the location 
within the cell to study ROS dynamics with Nrf2 paralog combat mechanisms 
simultaneously. 
 Another hypothesis is that the β-cells of the Nrf2a MO embryos survived the 
MTZ treatment due to a completely different method not directly involved in the Nrf2 
paralog pathways.  It has been described previously in literature that macrophages are 
recruited to injured β-cells upon stress signals. In the normal, lean state, islet 
macrophages promote islet development and maintenance of normal insulin secretion 
upon glucose stimulation [51].  It is possible that during oxidative stress conditions, and 
with the lack of a reliable Nrf2a protein to combat and stimulate the antioxidant response, 
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that these macrophages took over the protective role of the Nrf2 paralogs and promoted 
the survival of the β-cells captured in the images.   
 Fig. 11 shows a proposed model that describes possible mechanisms of the 
Nrf2a/Nrf2b dynamics and regulation in the β-cell under oxidative stress.  This model is 
based on the results from both the confocal microscopy and qPCR gene expression 
analyses.  At low levels of ROS in the β-cells, both Nrf2a and Nrf2b are upregulated and 
act together to combat ROS and suppress oxidative stress conditions.  At higher levels of 
ROS, a number of events could differ.  This includes: an additional increase in the Nrf2a 
levels to combat ROS, which could ultimately trigger stress-induced cellular apoptosis; 
and a compensatory upregulation of Nrf2b to combat ROS in the β-cell.  
 It is also important to consider similar protein isoform mechanisms in response to 
a stress signal that could provide additional insights to the Nrf2a/Nrf2b relationship 
dynamics.  A study by Thuerauf et al., 2004 investigated the roles of the ATF ER 
transmembrane protein isoforms, ATF6α and ATF6β, in ER stress response gene 
induction.  Their findings suggest that, while ER stress activates nuclear translocation and 
ER stress-response element (ERSE) binding for both ATF6 isoforms, they possess 
opposing roles in gene induction.  ATF6β inhibited ATF6α-mediated GRP78 promoter 
activation, as well as TN-mediated GRP78 promoter activation that require ATF6α.  The 
required levels of ATF6α and ATF6β for ER stress-response gene (ERSRG) induction 
also differ, providing evidence that ATF6β is a very poor activator of ERSRG induction 
as compared to ATF6α, and it represses ATF6α-mediated ERSRG induction.  ATF6β 
may serve as a transcriptional repressor to regulate ATF6α-activated ERSRG induction 
during stress response [52]. 
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 As with most scientific studies, there are limitations to these experiments that 
could provide further insights into this research.  One of the more important setbacks is 
the lack of reliable and functional antibodies for ZF Nrf2a and Nrf2b.  Although Nrf2 
antibodies have been previously used for fluorescence microscopy on zebrafish samples 
[53][54], they have not specifically been used on the pancreas and β-cells. Currently, 
there are no Nrf2a and Nrf2b antibodies available [55][56].  These would have been 
useful in the confocal microscopy analyses of the ZF islets under oxidative stress to 
visually see where Nrf2a and Nrf2b proteins are present and localize to under these 
conditions. These antibodies would also have been useful for protein quantification, 
especially in the Nrf2a morphants embryos, to quantitatively verify the specificity of the 
morpholino.  Current methods of detecting and quantifying proteins include, but are not 
limited to, Western blots, chromatography, enzyme-linked immunosorbent assay 
(ELISA), Bradford and Bicinchoninic Assay (BCA), and mass spectrometry [57].  
Implementing some of these techniques for this study would be important for further 
protein analyses.  
 Future experiments for this project are also suggestive as evident from the 
conclusions. It would be interesting to study Nrf2a knockout (KO) ZF embryos under 
oxidative stress conditions using the same Ins:NTR-MTZ system and experiments as 
done previously.  Nrf2a KO ZF would not have any Nrf2a protein produced in the 
organism throughout development, and would represent a phenotype which the Nrf2 
mechanism would be more heavily reliant on the Nrf2b protein.  Nrf2b mechanisms 
could be more specifically measured in Nrf2a KO, as well as provide additional insights 
to Nrf2a roles in combating ROS. 
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Figure 11.  Proposed mechanisms of ZF Nrf2 paralog dynamics in β-cell targeted 
ROS generation.  The top panel: low-dosage MTZ treatment triggers an increase 
in both Nrf2a and Nrf2b levels to suppress oxidative stress and ROS produced by 
the INS: NTR-MTZ chemical interactions.  Middle panel: high-dosage MTZ 
treatment triggers an additional increase in Nrf2a levels, which in turn promote 
stress-triggered apoptosis of the cell.  Nrf2b continues to combat ROS and 
suppress oxidative stress conditions.  Bottom panel: high-dosage MTZ treatment, 
induced in Nrf2a knockdown or knockout conditions, triggers a compensatory 
upregulation of Nrf2b to combat oxidative stress in β-cells.	
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 Another future experiment could be to investigate Nrf2b MO and perform the 
same ROS experiments and imaging analysis as for Nrf2a MO.  The conclusions and 
proposed model, with regards to Nrf2b dynamics, could be tested out with Nrf2b MO and 
even knockout fish.  Multiple fishlines can be created to feature Nrf2b knockouts. Similar 
to that of the ATF6 isoforms,  
 There could be some experiments performed with the different nrf2b splice 
variants to investigate if these transcribe any Nrf2b isoforms, and whether these have 
some special role in combating ROS in the β-cells.  Perhaps there is a preferred isoform 
of Nrf2b that the cell uses most in the antioxidant response that requires a mechanism 
other than that of Nrf2a.  There are several investigative questions that could arise with 
these hypotheses. 
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CONCLUSIONS AND SUMMARY 
 In summary, Diabetes remains a chronic metabolic condition that needs further 
understanding and insights into the biological aspects of the β-cell survival. During the 
pathogenesis of diabetes mellitus, β-cells are exposed to increased amounts of ROS that 
cause oxidative stress.  Oxidative stress plays an essential role in disruption of cellular 
homeostasis and can further cause cellular dysfunction and potential death.  The 
endogenous antioxidant response is the cell’s combat mechanism against oxidative stress 
and prevents the proliferation of damage. The Nrf2 transcription factor regulates the 
antioxidant response in cells by binding to AREs in DNA and activating genes of 
enzymes that combat oxidative stress. ZF have two paralogs of Nrf2, Nrf2a and Nrf2b, 
but their roles in pancreas development and/or islets are unknown.  With the use of 
antisense morpholino technology, we investigated pancreatic development, islet survival, 
and gene expression levels during oxidative stress conditions in Nrf2a and Nrf2b MO.  
We found that Nrf2a MO showed no obvious phenotypes compared to controls in 
pancreas development; however, Nrf2b MO embryos exhibited reduced pancreas size 
throughout development, and had islets with disrupted morphology. Ins:NTR tagged fish 
in Nrf2a MO showed a significant number of β-cell survival upon exposure to MTZ 
under ROS generation as compared to controls. Gene expression analysis of ZF nrf2a and 
nrf2b in MTZ-treated and control embryos revealed a slight increase in nrf2b expression 
in the morphants after 24hr MTZ. Sequence analysis of ZF nrf2a and nrf2b in 3dpf 
embryos revealed a novel splice variant of nrf2b containing an additional exon that has 
not yet been described. Sequence alignment with human and mouse Nrf2 variants 
revealed little to no significant similarities, suggesting specificity to ZF. Collectively, 
	 39 
these data suggest roles for Nrf2a and Nrf2b in the pancreas and islets that could provide 
insights into oxidative stress responses in diabetes pathogenesis. Further investigation of 
Nrf2a and Nrf2b is likely to yield additional insights regarding the function and 
regulation of the NRF2-signaling pathway and their roles in β-cell survival, and identify 
potential therapeutic targets for T1DM. 
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